LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,800,369 | -2.7% | 6,264,707 | 0.0% | 8.28% | +1.5% |
| Q2 2023 | $432,452,724 | +268.1% | 6,264,707 | +157.1% | 8.16% | +207.1% |
| Q1 2023 | $117,474,673 | -3.4% | 2,436,223 | 0.0% | 2.66% | +7.8% |
| Q4 2022 | $121,616,252 | +27.5% | 2,436,223 | +4.2% | 2.47% | +21.2% |
| Q3 2022 | $95,415,000 | +137.8% | 2,338,610 | +139.2% | 2.04% | +216.1% |
| Q2 2021 | $40,126,000 | -40.8% | 977,503 | -59.4% | 0.64% | -32.1% |
| Q4 2020 | $67,818,000 | -8.8% | 2,408,292 | 0.0% | 0.95% | -30.3% |
| Q3 2020 | $74,344,000 | -29.6% | 2,408,292 | -3.0% | 1.36% | -33.9% |
| Q2 2020 | $105,631,000 | – | 2,481,942 | – | 2.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |